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Summary 
In this study we define the proliferative compartments of in vivo human epidermis, using specific 
antibodies related to cell differentiation (/31 and 84 integrins and K1/K10 differentiation keratins) 
and cell cycle (proliferating cell nuclear antigen [PCNA]) in combination with flow cytometric 
quantitation of the DNA content and optical characteristics of the cells. The B1 integrin (CD29) 
marked both of the potentially proliferative subsets in normal epidermis. One subset of normal 
epidermis is CD29+K1/K10 - , which was predominantly basal, and found to be comprised of 
slow cycling, small cells with primitive cytoplasmic organization. The vast majority (95.5%) 
of these cells were in a quiescent  state (G0/early G1) as indicated by their lack of the cyclin, 
PCNA. The other proliferative subset of normal epidermis was CD29+K1/K10 +, which was 
suprabasal and occasional basal, highly proliferative, larger in size, and which exhibited a more 
complex cytoplasmic structure.  Because early differentiation  (K1/K10 expression) has begun in 
the CD29+K1/K10 + subset, it is highly likely that they represent the proliferative population 
which is capable of transiently amplifying itself before terminal differentiation.  Within lesional 
psoriatic  epidermis,  similar proliferative cell populations were present  as in normal epidermis, 
and  the  hyperproliferative  defect  was  localized  to  the  /31  and  /34  integrin  +,  K1/K10- 
populations, which in normal epidermis is basally located and quiescent with regard to cell cycle. 
In psoriatic epidermis, a six- to sevenfold increase in the number of cells in the S/G2 + M phase 
of cell cycle was  found among CD29+K1/K10 -  cells (p <0.05).  Furthermore,  all lesional 
K1/K10- cells showed high PCNA positivity,  indicating that all these cells had been recently 
induced into cell cycle. By contrast,  the proportion of cycling cells among lesional psoriatic 
CD29+K1/K10 + keratinocytes was similar to normals.  Anti-HLA-DR, CD45, and vimentin 
antibodies were used to concomitantly track the proliferative states of Langerhans cell, melanocyte, 
and infiltrating leukocyte populations. In normal epidermis, the cycling fractions (calls in S/G2/M 
phase) of these cells were similar  to the CD29§  -  keratinocytes,  whereas  in lesional 
epidermis their cycling pools were increased relative to normal, but not so much as the proliferative 
fractions of psoriatic CD29+K1/K10 -  keratinocytes. These data demonstrate the use of simul- 
taneous analysis of integrin expression, differentiation keratins, cyclin, cell cycle status, and optical 
characteristics  of freshly  isolated  human epidermal  cells. Such  analysis allowed the physical 
identification and quantification  of cycling populations  in normal human skin, and has enabled 
the precise localization  of the primary epidermal proliferative defect in psoriasis. 
T 
he epidermis  traditionally has been divided into three 
functionally different compartments: germinative, differ- 
entiated, and cornified. Increasing evidence suggests that the 
germinative compartment is heterogeneous (1, 2). In human 
epidermis,  Lavker and Sun (3,  4)  described  two different 
proliferating cell types: one consisted of slow cycling, "non- 
serrated" cells with primitive cytoplasm,  termed stem cells, 
and the other consisted of highly proliferative, "serrated" cells 
with more complex cytoplasmic organization, termed tran- 
siently amplifying cells. In vitro observations of human ker- 
atinocyte cultures  have provided additional  evidence of the 
existence of at least two functionally and morphologically 
different proliferating  keratinocytes. Small cell size has been 
observed to correlate with the colony-forming ability of ker- 
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tures of human epidermis revealed two proliferating popula- 
tions according to ceUular KNA and DNA content (6,  7). 
Dynamic assessment and physical identification of in vivo 
proliferative compartment subsets within human epidermis 
have been difficult because of the limitations of injecting ra- 
diolabeled nucleotides into subjects and the lack of a precise 
definition of the epidermal proliferative cell compartments. 
To identify pathological changes of epidermal proliferation 
in hyperproliferative skin conditions such as psoriasis,  it is 
first critical to directly quantitate proliferation in the mor- 
phologically and functionaUy different cell compartments of 
in vivo epidermis (8).  Methods using radiolabded nudeo- 
tides have been unable to directly measure proliferation in 
the different cell compartments of the epidermis. Previous 
ftow cytometric approaches have also not defined the prolifer- 
ative compartment subsets being examined (9). Although there 
is agreement that epidermal proliferation is devated in psori- 
asis (10) difficulties in measurement have led to controversy 
as to the localization and mechanism (decreased cell cycle time 
vs increased growth fraction) of the elevated DNA synthesis 
in psoriasis  (11, 12). 
We used four to five parameter flow cytometric analysis 
to study proliferation among in vivo epidermal subsets.  In 
addition to quantitating cell size and cytoplasmic complexity, 
keratinocyte proliferation can be measured through the use 
of DNA dyes (13).  DNA dyes circumvent the problem of 
cell metabolism of thymidine which can influence prolifera- 
tive data acquired by radiolabded thymidine incorporation 
(14, 15). Two groups of antigens are closely related to micro- 
anatomic location and stage of differentiation in the epidermis: 
adhesion molecules (16-25) and keratins (26-32). Using an- 
tibodies to the B1 and 84 integrins (the entire proliferative 
and strictly basal  compartments, respectively), and to the 
K1/K10 keratin pair (differentiating suprabasal compartment), 
we separated the epidermal cells according to their expres- 
sion of these specific antigens. By combining such staining 
with optical light scatter characteristics,  a fairly predse defini- 
tion of cell compartments was obtained. Subsequent analy- 
sis of DNA content and proliferating cell nuclear antigen 
(PCNA) 1 expression then allowed quantitation of the pro- 
liferative status of each subset in normal and psoriatic skin. 
Melanocyte, Langerhans call, and leukocyte contributions can 
be tracked by anti-CD45, anti-vimentin, and anti-HLA-DK. 
With this approach, we provide physical evidence that adult 
human interfollicular (and infundibular) epidermis harbors 
a primitive,  slow cycling population  and a rapidly cycling 
population which appears capable of transient amplification 
before terminal differentiation (3, 4). Furthermore, we localize 
the upregulation in psoriasis to occur only in the normally 
slow cycling, less differentiated subset. 
1 Abbreviations used in this  paper:. PCNA, proliferating  cell nuclear antigen; 
Pl, propidium iodide; 7AAD, 7 amino-actinomycin  D. 
Materials and Methods 
Human Subjects.  Keratome biopsies were taken from the but- 
to& area of normal volunteers and psoriasis vulgaris patients during 
the morning hours. Oral medication  was not allowed  in either group 
within 1 mo before the time when specimens were taken. In addi- 
tion, in the psoriatic group, external treatment was not allowed 
2 wk before the procedure. All lesional tissue represented inflamed 
but relatively stable psoriatic plaques. For tissue staining, 4-ram 
punch biopsies were taken from normal and lesional skin of the 
volunteers and psoriatic patients. 
Tissue Staining.  Frozen sections (2-4/~m) in OCT (Tissue Tec 
II; Miles Laboratories, Elkhart, IN) were fixed in 70% cold eth- 
anol for 10 rain at -20~  Indirect immunofluorescence staining 
was performed with anti-CD29, anti-K1/K10 antibodies, and iso- 
type controls, followed by FITC or rhodamine-conjugated second 
antibodies, as previously described (33). 
Epidermal  Cell Suspension.  After overnight treatment of kera- 
tome biopsies with Dispase (Collaborative Biomedical Products, 
Bedford, MA) at 4~  epidermis was removed from dermis. The 
epidermal sheet was placed into 0.25% trypsin (Sigma Chemical 
Co., St. Louis, MO) and incubated for 20 rain at 37~  A single 
cell suspension was then prepared in the presence of 0.01% DNase 
(Sigma Chemical Co.) and 10% FBS (Hyclone Laboratories, Logan, 
UT) by gentle teasing. The suspension was filtered through a 112 
/~m nylon mesh and washed. After the final wash,  cells were 
resuspended in 1 ml HBSS without phenol red, Ca  z+ and Mg  2+ 
(Irvine Scientific, Santa Aria, CA) and slowly pipetted into 30 ml 
70% cold ethanol. Samples were kept at  -20~  in ethanol until 
staining and flow cytometric analysis. 
Staining Procedure.  The ethanol-permeabilized ceils were cen- 
trifuged (10 min, 3,000 rpm) and resuspended in Hunk's solution. 
The suspension  was syringed through a 30 G needle  before staining. 
mAbs used were: anti-CD29 (4134; Coulter Immunology, Hialeah, 
FL), 1:20 dilution; anti-K1/K10 (AE2; ICN, Costa Mesa, CA), 
1:50 dilution; anti-CD45 (Ik-cton  Dickinson & Co., Mountain View, 
CA), 1:5 dilution; anti-HLA-DR-PE (Bectun Dickinson & Co.), 
1:5 dilution; anti-vimentin (ICN), 1:800 dilution; anti-B4 (Chem- 
icon International,  Inc., Temeeula, CA), 1:5,000 dilution;  anti- 
PCNA, 1:100 dilution (Boehringer Mannheim, Indianapolis, IN), 
and isotype controls, which included purified mouse IgG1 and as- 
cites mouse IgG1 (both from Sigma Chemical Co.), and purified 
mouse IgG2a (Pharmingen, San Diego, CA).  10% normal goat 
serum (Cedarlane  Laboratories, Hornby, Ontario, Canada) was used 
to block nonspecific binding.  Goat anti-mouse IgG1-FITC and 
IgG2a-PE (Boehringer Mannheim) were used as secondary anti- 
bodies at 1:100 and 1:80 dilutions, respectively. Double staining 
with anti-CD29  and anti-K1/K10 was carried out in four steps. 
After primary staining with anti-K1/K10 and second step staining 
with goat anti-mouse (FITC), the ceils were incubated with 10% 
normal mouse serum (Accurate  Chemical & Scientific  Corp., West- 
bury, NY) for 30 rain on ice and stained in the fourth step with 
PE-conjugated anti-CD29. The cells were then resuspended either 
in 50/~g/ml propidium iodide (PI) with 100 U/m1 RNase A (Sigma 
Chemical Co.) or 7 amino-actinomycin D [7AAD] (25 ~g/ml, 
Calbiochem Novabiochem Corp., San Diego, CA). Samples were 
analyzed within 24 h by flow cytometry. HLA-DR-PE and CD29- 
FITC double staining were performed before ethanol permeabili- 
zation, because ethanol pretreatment reduced HLA-DR visual- 
ization. 
Flow Cytometry.  Flow cytometry  was performed using an Epics 
Elite Flow Cytometer (Coulter Cytometry, Hialeah, FL). Light 
scatter, forward and 90  ~ was used for gating out debris and lyre- 
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granularity cell population of CD29+CD45 § cells). Ceil aggre- 
gates were eliminated from the DNA analysis based on the ratio 
of integrated to peak fluorescence of PI or 7AAD. Listmode data 
were analyzed using Elite Software (Coulter Corp.), and for cell 
cycle analysis, multicycle software from Phoenix Flow Systems (San 
Diego, CA) was used. 
Results 
Anti-CD29 and Anti-K1/KIO Antibodies Distinguish Basal 
from SuprabasaI  Epidermal Cells in Tissue  Sections.  To use flow 
cytometry to quantitate  proliferative compartments in the 
epidermis, antibodies that preferentially react with the prolifer- 
ative or nonproliferative compartments of epidermal cells were 
identified.  We  verified  by  indirect  immunofluorescence 
whether integrin and differentiation keratin antibodies de- 
tect distinct cellular compartsaents in in vivo human epidermis. 
In  normal  human  skin  a  mAb  to  the B1  subunit  of the 
CD49-CD29  integrin complex stained the basal layer and 
occasional second layer cells in the epidermis (Fig. 1 A). Anti- 
K1/K10  antibody staining, on the other hand, was limited 
to upper layers of the epidermis,  generally, but  not exclu- 
sively,  sparing  the basal layer  (Fig.  1 B). 
The same overall pattern of K1/K10 expression was ob- 
served in lesional psoriasis skin sections as in normals, in that 
K1/K10 expression was localized mainly above the CD29 + 
layers (Fig. 2 B). However, psoriatic skin differed from normal 
skin in CD29  expression,  in that  CD29  was expressed on 
the first two to three rows of lower cells in psoriatic epidermis 
(Fig.  2 A). 
Quantitation of Basal and Suprabasal Cell Compartments in 
Normal Epidermis by Flow Cytometry.  Epidermal cell suspen- 
sions prepared from normal skin keratome biopsies were stained 
with antibodies against CD29 and K1/K10 keratins or iso- 
type controls and analyzed by flow cytometry.  Consonant 
Figure  1.  Expression of/~1 integrin (CD29) and K1/K10 keratins in 
normal human skin. Sections  of normal human skin were stained with 
anti-CD29 (A) and anti-K1/K10 (B) mAbs. Whereas anti-CD29 stains 
the basal layer and occasional second layer ceils, anti-K1/K10 staining is 
limited to upper layer cells, sparing the basal layer. 
Figure  2.  Expression  of E1 integrin (CD29) and K1/K10 keratins  in 
psoriatic skin. Sections of lesional psoriatic skin stained with anti-CD29 
(A) and anti-K1/K10 (B) antibodies. Anti-CD29 positivity is apparent 
on the first two to three rows of basal cells, whereas anti-K1/K10 staining 
occurs  above the CD29-positive call layers. 
with the in vivo staining pattern described above, three major 
populations comprising 89.2  _+  7.1% (n  --  5) of the normal 
epidermal cells,  were detected by flow cytometry. Predomi- 
nantly basal cells were defined as CD29+K1/K10 -  and con- 
sisted of 20.7  _+  1.6%  of the stained epidermal cells (Fig. 
3 A, quadrant I). The suprabasal calls were identified based 
upon their positive expression of K1/K10 and could be divided 
into two populations depending upon their coexpression of 
CD29.  The majority of the epidermal cells were found in 
the  CD29-K1/K10 +  population  (Fig.  3  A,  quadrant  4). 
Another population of epidermal cells, which coexpressed 
CD29 and K1/K10 (CD29+K1/K10 + population) comprised 
r 
N 
A 
::  ~  ):  )  i??3i  i?i,:):  )i}?iii?ii.:  :.:::  ~ 
I  I  [ IHI~I  I  I HIHI  I I IIIIII  I  I IIlill 
￿9 I  1800 
K1/KIO  FITC 
B 
i 
_ 
.1 
1  2 
￿9  "  :-~.~i.;  ,  .-  :  ￿9  "  .  ( 
I  .......  I 
IIIm~.. '  3  '::, .... ..... 
J.OO0 
ISOTYPE  FITC 
Figure  3.  Identification of normal human epidermal cell populations 
by flow cytometry. Two-parameter scatter plot diagrams of a double-stained 
(anti-CD29 PE and anti-K1/K10 FITC) epidermal cell suspension  from 
normal human skin. Ceils with PE and FITC binding levels that fall within 
quadrant 3 (,4) exhibit negative staining that is not different  than back- 
ground fluorescence that occurs with double-isotype  staining (B). Double- 
positive  cells exhibiting higher than background fluorescence intensity for 
both fluorochromes are in quadrant 2. Cells positive for oaly a single marker 
fall into quadrant  1 (CD29+K1/K10 -) and quadrant  4 (CD29-K1/K10 + 
FITC). 
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Figure  4.  Light scatter analysis reveals two distinct CD29 + cell popu- 
lations. Larger cell size and cytoplasmic complexity of CD29+K1/K10 + 
cells versus CD29+K1/K10 -  cells. Anti-CD29 PE and anti-K1/K10 FITC 
double-stained normal epidermal cells were separated  according to their 
PE and FITC fluorescence.  CD29+K1/K10 -  (A) and CD29+K1/K10 + 
(B) cells appear as distinct groups on the dual-parameter forward light 
scatter (y axis, expressed as log) versus 90  ~ angle light scatter (x axis, ex- 
pressed  as log). 
13.8  +_ 3.2% of stained epidermal cells (Fig. 3 A, quadrant 
2). The CD29+K1/K10 + cell type has not previously been 
described, although its existence can be inferred based upon 
immunoelectron microscopic demonstration  of K1/K10 + 
cells in the basal layer (34) and reports of occasional CD29 + 
cells in the second layer of the epidermis (21). 
Light Scatter Analysis Separates the CD29 + Compartment into 
Two Populations  Based upon their Expression of K1/KlO.  Light 
scatter  analysis  of the  CD29 +  cell  population in  normal 
epidermis revealed that the CD29 + K1/K10-  basal cells and 
the  CD29+K1/K10 +,  more differentiated,  cells  represent 
different populations by size and cytoplasmic complexity (35). 
In comparison with  the K1/K10-  population (Fig.  4 A, 
lower left quadrant),  K1/K10 + cells are larger and exhibit 
the more complex cytoplasmic structures (Fig. 4 B, upper 
left and upper right quadrants) expected of differentiating 
keratinocytes. 
CD29 Expression Distinguishes between  Proliferative  and Non- 
proliferative Compartments in Normal Epidermis.  To define the 
epidermal proliferative compartment, epidermal cells were 
simultaneously stained with anti-CD29, anti-K1/K10, or iso- 
type control antibody in combination with DNA dyes such 
as PI and 7AAD. DNA staining in combination with specific 
antibody permitted determination of cycling (S/G2/M phase 
cells) and noncycling (GO/G1) states of specific epidermal com- 
partments (Fig. 5). With this approach, it is clear that the 
entire pool of proliferating cells (S/G2/M) are CD29 + (Fig. 
5  A).  Using  anti-K1/K10,  the  proliferating  CD29 +  cell 
population can be subdivided into two main subsets (Fig. 
5 B). One lacked K1/K10 and the other coexpressed K1/K10. 
In studies of keratinocytes cultured long-term in vitro, two 
populations of proliferating keratinocytes have been observed 
(7). Small cells were found to be slowly cycling whereas the 
more rapidly proliferating cell population consisted of large 
cells. It has been suggested that the slowly cycling small popu- 
lation had stem cell properties and that the larger cells repre- 
sented transiently amplifying keratinocytes. We asked whether 
similar  mitotic  properties  would be  exhibited by  human 
epidermal cells in vivo. Therefore, the DNA content of the 
small  CD29 +  and  large  CD29 +  cells  were  analyzed 
separately.  Among the  small CD29 +  cells,  5.16  +  1.8% 
cells were found in S/G2/M phase, whereas 16.6  _+  4.54% 
of the large CD29 + cells were in cycle (n  =  5;  data not 
shown). 
Separation of Proliferative Compartment of Normal Epidermis 
into Slow-Cycling CD29+ K1/KlO -  Cells and Rapidly Cycling 
CD29+K1KlO + Cells.  Because there is a continuity in size 
and granularity  among the CD29 +  epidermal cells,  espe- 
ciaUy in the psoriatic epidermis, separation of the ceils into 
a small and large group for further analysis would be some- 
what arbitrary.  Therefore, K1/K10 expression was used to 
separate the proliferative CD29 + cells into subpopulations, 
and triple-color analysis utilized to simultaneously quanti- 
tate DNA content with another DNA dye, 7AAD. Indeed, 
the DNA analysis (Fig. 6) revealed a great difference in mi- 
totic activity between CD29+K1/K10 -  (4.53  _+  1.1%, Fig. 
6 A) and CD29+K1/K10 + cdls (48.8  __  18.92%, Fig. 6 B) 
(n =  3). This disparity in cycling pool was greater than that 
seen between the CD29 +  small and CD29 + large group, 
confirming our suspicion that some slow cycling K1/K10- 
cells can exhibit a log forward light scatter (LFLS) indistin- 
guishable from K1/KIO + cells. 
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Figure  5.  Proliferative state of 
epidermal  cell  subsets in normal 
skin determined by DNA content. 
Two-parameter scatter plot of nor- 
mal human epidermal cells stained 
separately with anti-CD29 (A,  y 
axe), anti-K1/K10 mAbs (Bi y axis), 
and isotypc control (C, y axis) in 
combination  with propidium iodide 
(PI, x axis). Proliferating cells (cells 
in S/G2/M phase) all express CD29 
(A,  upper right)  relative to isotype 
control ( C, lower right). Proliferating 
cells  can be  either  K1/K10 §  (B~ 
upper right)  or KI/KIO-  (B~ lower 
right). 
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Figure 6.  Call cycle analysis of epidermal cell subsets by triple-color flow cytometry. Normal epidermal cells simultaneously costained with anti- 
CD29 PE, anti-K1/KlO FITC, and 7AAD. Cells were separated according to their PE and FITC fluorescence intensity into CD29+K1/K10 -  (A) 
and CD29  +  K1/K10 + (B) groups• The number of cells with a given DNA content is expressed  as number of cells versus 7AAD fluorescence  (x axis). 
(Dashed line) Histogram  of the experimental  data (dots). (Shaded  areas) The best curve  fit calculated  by the multicycle  software  package (Phoenix  Flow 
Systems) to separately  resolve the distribution of cells in GO/G1 (gray shading), S (diagonal lines), and G2/M (dense shading) phase of the cell cycle. 
These data provide, for the first time, a direct demonstra- 
tion that the proliferative compartment of in vivo human 
epidermis is characterized by CD29 expression and consists 
of at least two morphologically and functionally different com- 
partments. One compartment mainly contains slowly cycling 
CD29+K1/K10 -  small cells with a relatively simple internal 
structure. The other proliferative compartment contains rapidly 
proliferating CD29 +K1/K10 + larger cells with more com- 
plex cytoplasmic organization. 
Contribution  of Nonkeratinocyte CD29 + Cells to the Prolifer- 
ative Compartment of CD29+ K1/KIO -  Epidermal Cells.  Al- 
though expression of K1/K10 is specific for keratinocytes, anti- 
CD29 recognizes the E1 integrin chain and may be expressed 
on other cells in the epidermis, such as melanocytes, Langer- 
hans cells, or T  cells. To verify whether our DNA analysis 
truly represents  the proliferative state of the keratinocyte 
CD29 +  K1/K10-  population, we utilized monodonal anti- 
vimentin, anti-HLA-DK, and anti-CD45 antibodies to iden- 
tify mdanocytes, Langerhans cells, and lymphocytes in our 
epidermal cell suspension. In agreement with previous results 
(21, 36-38), in normal epidermis, all the DK- and vimentin- 
positive cells showed double staining with anti-CD29 (data 
not shown), indicating that the B1 integrin is indeed present 
on Langerhans cells and mdanocytes. Although the number 
of Langerhans cells and melanocytes in the normal epidermis 
is relatively low compared with the CD29 +  K1/K10-  epider- 
mal cells (Table 1), DNA staining (PI) of CD45 and vimentin- 
stained normal epidermal cells was performed to determine the 
contribution that mdanocyte and Langerhans cell proliferation 
could have on the DNA analysis  of the CD29 +  K1/K10- 
population. Vimentin- and CD45-positive cells exhibited a 
cycling pool (percentage of that cell type that is in S/G2/M 
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phase of the cell cycle) similar to CD29+K1/K10 -  cells in 
normal epidermis (5, 6, and 4%, respectively, Table 1), and 
they comprised one fourth of the cycling population in normal 
epidermis (0.25% vimentin-positive cycling cells within 1.05% 
total CD29 + cycling cells)  (Table  1). 
CD29 +K1/KIO-  Keratinocytes Are Responsible for Hyperpro- 
liferation in Lesional Psoriatic Epidermix  Cytometric methods 
for analysis of freshly isolated human epidermal cells were 
applied to quantitate and localize alterations in the proliferative 
compartments of lesional psoriatic epidermal cells. Similar sub- 
populations were found in the lesional epidermal cells stained 
with anti-CD29 and anti-K1/K10 as were found in normal: 
CD29+K1/K10 -  (Fig. 7 A, quadrant I), CD29+K1/K10 + 
(Fig.  7 A,  quadrant  2)  and CD29-K1/K10 ÷  (Fig.  7 A, 
quadrant 4), but the overall pattern differed somewhat, in 
that there were more cells found in the rightmost portion 
of quadrant I  and the leftmost portion of quadrant 2 (Fig. 
7 A). Although the cells in quadrant 1 must be considered 
to be K1/K10-  based on the isotype staining (Fig.  7 b), the 
cells in the leftmost portion of quadrant 2  (Fig.  7 A) can 
be considered to be K1/K10  ~m, indicating a transitional state 
of early K1/K10 expression. 
As in normal epidermis, the proliferative compartment 
(S/G2/M) of the psoriatic epidermis was entirely comprised 
of CD29 + cells (Fig. 8 A), ceils above the horizontal cursor 
for CD29 + calls defined by the isotype control (Fig.  8 C). 
One difference, however, was the presence of a CD29-K1/ 
K10  ~m "S" phase cell population, with much variability in 
size (ranging from 0.7 to 9% of total epidermal cells in in- 
dividual samples) in the psoriatic samples (Fig. 8, cells with 
>2 n DNA below the horizontal cursor). This population 
is never present in normal samples. Table  1.  The Elevated Proliferative Rate of CD29 + Cells in Lesional Psoriasis Is Due  To an Enlarged Cycling Pool of 
CD29+KI/KlO -  Keratinocytes and Not to CD29 + Lymphocytes  , Langerhans Cells, Macrophages, or Melanocytes 
Cycling subset  cells 
as a proportion of each 
cell subset 
Cell population size 
(%  total EC) 
Cycling subset  cells as a 
proportion of total EC 
(%  total EC) 
Normal 
Vimentin +  (n  =  2)  5%*  4.5  _+ 0.5*  0.25  _+ 0.05s 
CD45 +  (n  =  4)  6%  2.08  _+ 0.08  0.125  _+ 0.0025 
CD29+K1/K10 -  (n  =  3)  4%  23.2  _+  1.6  1.05  _+ 0.27 
Lesional psoriatic 
Vimentin +  (n  =  2)  11%  6.75  +  3.3  0.75  _+ 0.15 
CD45 +  (n  =  4)  17%  5.25  _+  1.6  0.9  _+ 0.3 
CD29+K1/K10 -  (n  =  3)  25%  30.76  _+  8.1  7.8  _+ 0.9 
*  The percentage of cells within each call subset that is in S/G2/M [cycling  subset cells as a proportion of each subset =  100(call population size/cy- 
cling subset cells as a proportion of total EC)]. 
t The percentage of cells expressing this marker as a percentage of total epidermal cells (EC). 
S Proportion of each subset that is in S/G2/M as a percentage of total EC. 
In psoriasis, the vast majority of the proliferating cells are 
clearly  K1/K10-  (Fig.  8  B,  S/G2/M  cells  below  the 
horizontal cursor), based on the isotype staining (Fig. 8 C). 
Of interest is the slightly increased presence of a cluster of 
G2/M cells just above the horizontal cursor in psoriasis (Fig. 
8 B) relative to normals (Fig. 5 B), again consistent with an 
increase in transitional cells (K1/K10'~m). 
The two proliferating populations in the normal and le- 
sional psoriatic epidermis exhibit the same relative propor- 
tions (Table 2), suggesting a parallel expansion of these two 
populations in lesional psoriatic skin. However, comparison 
of the mitotic activity of proliferative compartment subsets 
in normal and in diseased epidermis revealed a fundamental 
and robust difference between normal and psoriatic skin (Fig. 
9).  On the one hand, a major difference in the number of 
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Figure 7.  I~'mtification  of  psoriatic epidermal  cell  subsets  by flow  cytom- 
etry. Two-parameter scatter plot of lesional psoriatic epidermal cells co- 
stained with anti-CD29 PE and anti-K1/K10  FITC. Background  staining 
and cursor placement is determined  by double isotype staining (B). Cells 
expressing both antigens fall within quadrant 2 (A). Quadrant I contains 
CD29+K1/K10  - calls and CD29-K1/K10 + cells are in quadrant 4 (A). 
S/G2/M phase cells  among the CD29+K1/K10 -  cells was 
detected in lesional psoriatic epidermis upon comparison with 
normal (28.06  +  8.9% in lesional psoriasis vs 4.53  _+  1.31% 
in normal, p  <0.05).  On the other hand,  the cycling pool 
(S/G2/M phase cells) within the CD29 +K1/K10 + differen- 
tiating transiently amplifying cells was almost the same in 
normals and psoriatics. 
The finding that the same mitotic activity is present in 
the normal and lesional psoriatic CD29 +  K1/K10 + transient 
amplifying cells indicates that there is no inherent change 
in proliferation among the transiently amplifying keratino- 
cytes in lesional epidermis.  In addition,  the proportion  of 
CD29+K1/K10 -  cells that differentiate to express K1/K10 
is the same for both normal and psoriatic CD29+K1/K10 - 
cells. 
Hyperproliferation in the Psoriatic Epidermis  Is Due to Activa- 
tion of the Normally Quiescent  Cells  in the CD29+K1/KlO - 
Basal Cell Compartment.  Although stem cells must be con- 
tained within the CD29+K1/K10 -  cell population, they do 
not comprise the entire subset. To determine whether all of 
the cells in this compartment are affected by the hyperprolifer- 
ative signal,  we combined  K1/K10  staining with  PCNA 
staining. PCNA begins to accumulate during the G1 phase 
of the cell cycle, is most abundant during S phase, and declines 
during  G2/M  phase  (39).  In  normal  epidermis  the  vast 
majority (95.5%) of the K1/K10-  cells were PCNA nega- 
tive, indicating quiescent state (Fig. 10 A), consistent with 
a large component of slow cycling cells. By contrast, in psori- 
atic epidermis, all of the K1/K10- cells showed PCNA posi- 
tivity (Fig.  10 B, upward shift of dark dot plot relative to 
isotype-stained cells represented by counter plot). These data 
suggest that the entire CD29 § K1/K10- cell population has 
recently entered cell cycle in psoriatic epidermis, indicating 
that stem cells, which must be contained in this population, 
are affected by the hyperproliferative signal(s). 
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Figure 8.  Proliferative state  of 
epidermal  ceU subsets in lesional 
psoriatic skin determined  by DNA 
content. Two-parameter  scatter plot 
of lesional psoriatic epidermal cells 
stained with anti-CD29 FITC (A) 
or anti K1/K10 FITC (B). Positivity 
is  determined by  isotype  FITC 
staining (C). Ceils in S/G2/M phase 
are  CD29 +  (A)  and either K1/ 
K10-  or  K1/K10 +  (B).  A  few 
CD29-  cells can be observed in 
early S phase. 
Identification, Quantification, and Removal of the Leukocytic 
and Melanocl/tic Proliferative Compartment.  In  addition  to 
Langerhans cells and melanocytes, activated T  lymphocytes 
and macrophages are present in the CD29 + compartment 
of lesional psoriatic epidermis (40-45). Among the total epi- 
dermal cell population,  the percentage of CD45 + cells is 
consistently higher in the lesional psoriatic samples (5.25  _ 
1.6%) than in normals (2.08  _  0.06%)  (Table 1) (n  ---  4). 
However, the proportion of cells in S/G2/M phase within 
each subset among the vimentin- and CD45-positive cells 
is less than among the entire CD29+K1/K10 -  cell popula- 
tion,  (vimentin +,  11%;  CD45 §  17%;  and  CD29+K1/ 
K10-,  25%;  Table  1),  suggesting that  the 25%  figure is 
a  minimal  estimate  of the  lesional  psoriatic  keratinocyte 
CD29 + K1/K10-  subset cycling pool. Vimentin § leukocytes, 
Langerhans cells,  and melanocytes comprised less than one 
tenth of the cycling population (0.75%  vimentin §  versus 
7.8%  CD29§  -  epidermal cells are in cycle)  (Table 
1).  The above findings cause DNA  analysis of the lesional 
psoriatic CD29+K1/K10 -  population to somewhat under- 
estimate the proliferation of the keratinocytes (because of the 
inclusion of less proliferative melanocytes, Langerhans cells, 
and lymphocytes in the analysis). Thus the difference in the 
number of S/G2/M cells, among CD29+K1/K10 -  keratino- 
cytes between normal versus lesional psoriatic epidermis, is 
even higher than the sevenfold increase demonstrated in Table 
1, column 3. 
Hlq~proliferation among Strictly Basal fl4 Integrin + Keratino- 
cytes.  To further verify that stimulation of the normally slow 
Table  2.  The Relative Proportions of the CD29 + Proliferative 
Cell Compartments Are the Same in Normal and 
Psoriatic Epidermis 
CD29 +  K1/KI0-  CD29 §  K1/K10 § 
Normal  65.4 _+ 4.8  34.6 _+ 4.8 
Psoriatic  65.4 +  9.3  34.6 +  9.3 
Percentages were calculated in five independent anti-CD29 PE and anti- 
K1/K10 HTC double-staining experiments for both the normal and psori- 
atic groups. Values are expressed as averages +  SE in each group. 
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cycling strictly basal cell population is responsible for hyper- 
proliferation in psoriatic lesions, and not a CD29 + population 
which has differentiated but delayed K1/K10 expression, we 
used/34 integrin to further subdivide the CD29 + K1/K10- 
cell population. 84 integrin is strongly localized to hemides- 
mosomes, suggesting that it plays a role in epidermal cell 
adhesion to the basement membrane (25).  Contrary to/31 
integrin in psoriatic lesional tissue,/34 integrin staining in 
psoriasis is identical to normals, in that it is restricted to the 
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Figure 9.  Cell cycle analysis localizes the hyperproliferative defect in 
lesional psoriasis to be within the CD29*K1/K10- cell  compartment. 
Epidermal cells from  normal (n  =  3) (solid bars)  and lesional psoriatic 
(n = 3) (stiFfled bars) skin were costained with anti-CD29 PE, anti-K1/K10 
FITC, and the DNA dye, 7AAD. Based upon PE and PITC fluorescence, 
cells were electronically separated into CD29+K1/K10 -  (left bars) and 
CD29+K1/K10 + (right bars) populations and the DNA distribution based 
on 7AAD fluorescence was analyzed by the Multi~:le software package 
(Phoenix Flow Systems). The percentage of cells in each epidermal cell 
subset that has entered cell cycle (S/G2/M) is expressed as the average _+ 
SE from three normals and three psoriatics. The difference  in the percentage 
of S/G2/M ceils among the CD29*K1/K10- cells  between normal and 
psoriatic epidermal cells is significant (p <0.05) as assessed by two-tailed 
Student's t test. By contrast,  the more differentiated K1/K10 + subset ex- 
hibits identical proliferation  in normal and psoriatic  skin. vs 
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Figure  10.  PCNA and K1/K10 double staining of normal and psori- 
atic involved epidermis.  K1/K10- cells are electronically gated according 
to FITC (K1/K10)  fluorescence in normal (A) and in psoriatic involved 
(B) epidermis. Two-parameter diagrams show PCNA PE staining (dot  p/ots, 
y axis) and isotype control staining (counter plots, 2/axis)  versus forward 
angle light  scatter (x  axes).  In  normal epidermis, only 4.5%  of the 
K1/K10- cells show PCNA positivity (dots above the outermost line of 
the counter plot diagram, A)  whereas  in  psoriatic epidermis all the 
K1/K10-  cells exhibit high PCNA PE fluorescence (dot plots B). 
basal pole of the very first layer of cells above the basement 
membrane (46).  In normal epidermis 84 integrin-positive 
cells (84 FITC, Fig. 11 A) were identified as a minor popula- 
tion exhibiting FITC fluorescence above the cursor for posi- 
tivity defined by the isotype control (data not shown). Qual- 
itatively, it can be appreciated that many 84 integrin-positive 
cells in lesional  psoriatic epidermis express DNA content 
(DNA PI) >2 n (Fig.  11 B). Quantitation of the cell cycle 
status of 84 integrin-positive lesional psoriatic keratinocytes 
revealed a marked hyperproliferation (31%  of 84 + cells in 
S/G2/M phase) in comparison with normal cells (3.9% of 
84 + cells in S/G2/M phase). 
Discussion 
An accurate comparison of keratinocyte proliferation be- 
tween normal and pathological proliferative  conditions re- 
quires the development of methods to simultaneously define 
and quantitate proliferative compartment subsets within the 
epidermis. Several specific markers are known to bind to the 
basal cells of normal epidermis, but none of them have proven 
to be exclusive markers of the proliferative populations (17, 
34,  47-49).  It  is  widely accepted  now that  cell  markers 
specifically expressed on basal layer cells do not define the 
total proliferative compartment in normal epidermis. Mitotic 
cells as well as thymidine incorporation occur among suprabasal 
cells (50,  51). 
The 81 integrin chain is expressed predominantly on basal 
cells, but also on some suprabasal cells upon staining of ver- 
tical sections of epidermis. In this report, we show by flow 
cytometric analysis that CD29 identifies all of the prolifer- 
ating cells in the epidermis. Cytoplasmic expression of the 
differentiation keratin pair, K1/K10, was used to more pre- 
cisely relate in vitro flow cytometric results to in vivo tissue 
location  and  to  separate  more  highly differentiated cells 
(CD29- K1/K10 +) from the proliferative compartment cells. 
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/~4 integrin-positive basal cells in psoriatic epidermis are 
in hyperproliferative  state. DNA content of normal (A, x axis) and psori- 
atic involved (B~ x axis) epidermal cells./~4 integrin-positive cells in the 
psoriatic sample (top, B) contain a higher number of cells in S/G2/M phase 
(dot plots)  than/34 integrin-positive cells in the normal sample (top, A). 
Cursors for positive FITC fluorescence (y axes) are set according to isotype 
background staining (data not shown). 
The appearance of K1/K10 keratin in keratinocytes  is con- 
sidered to be one of the first signs of differentiation (29, 31). 
Surprisingly, K1/K10, which by light microscopy stains the 
epidermis  from  the  suprabasal  layer  up  to  the  stratum 
granulosum, was  expressed  on a large  number of cycling 
(S/G2/M) CD29 + cells in normal epidermis. By immuno- 
electron  microscopy  it  has  been  shown  that  K1/K10 + 
proliferating cells are present in the basal layer, but that they 
are slightly unattached from the basal membrane (34). Thus, 
the proliferative compartment of the human in vivo epidermis 
contains two subpopulations characterized  by CD29  and 
K1/K10 expression. Undifferentiated CD29 +  K1/K10- cells 
in  the basal  layer  express  K1/K10  upon commitment to 
differentiation and disattachment from the basement mem- 
brane.  Initially,  they retain CD29, but begin migrating up 
into suprabasal layers. Cells in this latter state of differentia- 
tion proliferate briskly, but proliferative capacity ceases in as- 
sociation with loss of CD29 expression.  At present, there 
are no data available of the precise three-dimensional organi- 
zation of the human epidermis. Comparison of data acquired 
by flow cytometry with the staining of tissue sections can 
only be approximative. 
Because CD29 staining can separate the heterogeneous  pro- 
liferative compartment from the nonproliferative compart- 
ment and K1/K10 expression further subdivides the prolifer- 
1278  Proliferative  Populations in Normal and Psoriatic Epidermis ative subpopulations, we were able to quantify the proliferative 
state of each CD29 + subpopulation separately. DNA analysis 
revealed that the different subpopulations of CD29 + keratino- 
cytes in normal human epidermis differ greatly in the number 
of proliferating cells.  The CD29 + cells that have initiated 
their differentiation program, as indicated by the expression 
of K1/K10 keratins, are highly proliferative in comparison 
to the nondifferentiating cells (CD29+K1/K10-).  The un- 
differentiated basal CD29+K1/K10 -  cell subset has few cells 
in cycle (4.5% PCNA + cells in one particular sample). The 
vast  majority of the cells are in quiescent  state  (PCNA- 
cells).  Besides keratinocytes, Langerhans cells and melano- 
cytes are included in the CD29+K1/K10 -  population. Us- 
ing mAbs that bind Langerhans cells and melanocytes, we 
were able to further subdivide the CD29+K1/K10 -  popu- 
lations, and found that Langerhans cells and melanocytes ex- 
hibit a cycling pool similar to the CD29+K1/K10 -  slow cy- 
cling keratinocytes in normal epidermis. They comprise about 
one fourth of the proliferative pool because of their low fre- 
quency in the epidermis, relative to CD29+K1/K10 -  ker- 
atinocytes. 
Determining the proliferative state of the keratinocytes by 
DNA content using DNA dyes circumvents the problem of 
differential thymidine metabolism in normal and diseased ker- 
atinocytes.  It has been shown that thymidine salvage and 
catabolism can be substantially different in proliferating versus 
differentiating cells in vitro (14).  In addition, we found that 
psoriatic epidermis, relative to normal epidermis, demonstrates 
markedly increased thymidine phosphorylase activity (15), 
which could result in decreased incorporation of exogenous 
thymidine in psoriatic tissue. 
It is now considered that the major difference between stem 
cells and differentiated cells in self-renewing tissues lies in 
their "unlimited" versus "limited" proliferative potential. In 
other words, differentiated cells can be highly reproductive 
through a limited number of cell cycles, whereas stem cells 
have the potential for unlimited numbers of cell cycles, but 
are not necessarily highly reproductive (52).  The existence 
of such a stem cell population in the human epidermis was 
strongly supported by the observations of Lavker and Sun 
(3). In human palmar epidermis they observed two distinct 
basal cell types. One type, resembling stem cells, was non- 
serrated, slowly cycling, and primitive in cytoplasmic struc- 
ture, whereas the other type, considered to be transiently am- 
plifying cells, exhibited more complex cytoplasmic structure 
and was highly proliferative. Our flow cytometric analysis 
of the two different proliferative subpopulations in normal 
epidermis  reveals  similar  subset  features;  the  CD29+K1/ 
K10-  and 84 integrin + basal cells are slow cycling, small in 
cell size (low LFLS), and primitive in cytoplasmic structure 
(low complexity or L90LS).  By contrast  the CD29+K1/ 
K10 + cells are highly proliferative, larger in size, and exhibit 
a more complex cytoplasm (higher L90LS). These data sug- 
gest  that  the  CD29 +  keratinocyte  subpopulations indeed 
contain stem and transiently amplifying subpopulations com- 
prising the epidermal proliferative compartment. Although 
we cannot further specify the CD29+K1/K10 -  stem cell- 
containing population, it is clear that the putative stem cells 
must be present within this population. 
In tissue sections of lesional psoriatic epidermis, the first 
two to three rows of proliferating cells are CD29 +, whereas 
K1/K10 occurs above the proliferative layers.  Flow analysis 
of the anti-CD29 and anti-K1/K10 double-stained samples 
revealed the presence of similar proliferating keratinocyte sub- 
populations (CD29 + K1/K10-  and CD29 + K1/K10 +)  and 
nonproliferative compartment cells (CD29-K1/K10 +) in le- 
sional psoriatic epidermis as in normal epidermis. 
Characterization of the germinative compartment within 
the proliferative compartments permitted identification of the 
major proliferative difference between normal and lesional 
psoriatic tissue. Epidermal expansion appears due to the con- 
siderably increased percentage of cells in S/G2/M phase of 
the cell cycle among  the CD29+K1/K10 -  as  well as  84 
integrin + basal cells. By comparison, the CD29+K1/K10 + 
more differentiated cells exhibited almost the same high fre- 
quency of cycling cells in psoriatic as in normal epidermal 
cells. The striking difference apparent with PCNA staining 
among K1/K10-  cells in the psoriatic tissue indicates that 
all the cells in this compartment of the psoriatic tissue left 
quiescent state. In contrast to this data, in a previous study 
using flow cytometry to analyze basal (low cellular RNA) 
and amplifying (high cellular 1LNA) keratinocytes, Staiano- 
Coico et al. (9) found an increase in the number of the am- 
plifying, high cellular RNA cells in psoriatic epidermis rela- 
tive to normal, and they concluded that the induction of the 
psoriatic  plaque  involves the  induction of an  unbalanced 
growth state within the more rapidly dividing keratinocyte 
population.  The main reason for the contradicting results 
lies  in  the  markers  used  for  defining  and  separating  the 
epidermal cell compartments. Cellular RNA content similar 
to cell size and granularity is continuous, resulting in some- 
what arbitrary separation between cell populations. Further- 
more, cellular RNA,  cell size,  and granularity can change 
with proliferative activation, therefore proliferating basal cells 
could show up as transient cells in psoriatic epidermis based 
on these markers, regardless of their true differentiation status. 
Our flow cytometry-based data confirm and precisely lo- 
calize data suggesting that the growth fraction (proliferating 
cells at any given time) is considerably increased in the psori- 
atic tissue (53). However, according to our data, the increased 
number of cycling keratinocytes in the psoriatic CD29+K1/ 
K10-  compartment did not result in an increase in the size 
of this cell compartment in psoriatic epidermis relative to 
the CD29+K1/K10 § cells with transient amplifying cell fea- 
tures. This suggests that the proportion of CD29+K1/K10 - 
cells that  self-renew  (to CD29+K1/K10 -)  is  the  same in 
psoriatic epidermis as  it is in normal epidermis, and that 
excess cells are committed toward differentiation (CD29 +K1/ 
K10~m). The ratio of CD29+K1/K10 -  to CD29+K1/K10 + 
cells could only be kept constant (Table 2) if there was ac- 
celerated maturation among the newly generated transient 
amplifying cells, and concomitant loss of CD29. Such an event 
is consistent with the accelerated differentiation pattern that 
psoriatic keratinocytes are known to undergo (54,  55). 
1279  Bata-Csorgo et al. Techniques  involving  simultaneous  analysis  of multiple 
parameters  of epidermal  cells  have  allowed us to precisely 
localize the epidermal proliferative defect in psoriasis to be 
within the normally slow cycling basal keratinocyte cell popu- 
lation which includes the stem cells. This finding will facili- 
tate the elucidation of the signal(s) responsible for the marked- 
over stimulation of this subset. Because these presented data 
provide a better understanding of the proliferative function 
of normal skin, the application of this technique in the inves- 
tigation of other hyperproliferative skin disorders will most 
likely help to precisely identify proliferative changes in different 
dermatoses. 
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